|
Corporate Scientific Advisory Board |
|
|
|
|
"The Corporate Scientific
Advisory Board serves as important component of AAHIVM's evolving
corporate partnerships, and reflects the collaborative spirit with
which we seek to achieve our shared vision of effective, accessible and
deliverable HIV care for all Americans"
-- James M. Friedman, Executive Director, American Academy of HIV Medicine
AAHIVM's Corporate Scientific Advisory
Board (CSAB) is comprised
of senior scientific and medical officers from
pharmaceutical, biotech and diagnostic companies developing
products for HIV treatment and diagnosis. The CSAB was formed 2008 to help AAHIVM provide its nearly 2500 members and credentialed HIV Specialists™ with first-hand, up-to-date scientific pharmaceutical information on current and cutting edge HIV treatment options.
For more information about the activities of the CSAB, or for information about how your company can become involved as a CSAB member, contact AAHIVM Executive Director James Friedman at 202-659-0699, ext. 17.

|
Corklin Steinhart, MD, PhD, FACP, AAHIVS
Senior Medical Director, HIV
Michael Harbour, MD, AAHIVS
Senior Medical Director, HIV
| 
| Bill
Guyer, PharmD
Director, Medical Education
| 
| Ron Falcon, MD
Vice President, Therapeutics Clinical Affairs |
|